Tom Brobson wore an artificial pancreas (AP) in the real world for three days as part of a JDRF-funded clinical trial. Leaving the hospital setting behind, Tom was able to live life while a smartphone-based AP system helped to automatically manage his blood glucose. The AP is one part of JDRF’s overall research vision. Please join us to hear about Tom’s compelling experience, and the promise that JDRF funded research holds for all people with T1D.
This event will take place in two locations connected via live satellite. Hear from and ask questions of all of our speakers from either location:
Medtronic World Headquarters
710 Medtronic Parkway, Fridley, MN
In South Dakota:
Sanford Research Center
2301 E 60th Street North, Sioux Falls, MN
Can’t make it to either location? No problem! This session is to be recorded and we’ll have the link available for you. Check back here or on our Facebook page for updates and we’ll have it available as soon as possible.
- 6:00 PM – Reception for MN guests begins. Tour of Sanford Research Center for SD guests
- 6:30 PM – Chapter Announcements
- 6:45 PM – Overview of JDRF’s research goals and strategies; Patricia Kilian, Ph.D, JDRF Director, Beta Cell Therapies, Regeneration; Julia Greenstein, Ph.D, JDRF Assistant Vice President, Cure Therapies
- 7:30 PM – Keynote Address: My Story- The Artificial Pancreas in the Real World: Tom Brobson, JDRF National Director, Research Investment Opportunities
RSVP by April 22 to MinnDakotas@jdrf.org or 1-800-663-1860. Please indicate which location you’ll be attending and provide the names of all guests, including any children you will be bringing to childcare. This program is free and open to the public.
- Appetizers and beverages will be served. Gluten free options will be available.
- Childcare for children ages 3-12 is available at no charge in both locations. Childcare will open at 5:45 PM to allow adult guests time to drop off children and attend the reception or tour. Please share the names and ages of all children you will be bringing to childcare when you RSVP.
- If you require any special accommodations, please contact us in advance so we can best serve you at the event.
About our speakers:
Tom Brobson, National Director, Research Investment Opportunities
Tom Brobson joined the JDRF staff in 2005 and has worn a number of hats while at JDRF working in the development area, research, and communications. He was instrumental in launching the Research Information Volunteer Program (RIV) – a cadre of volunteers from chapters around the country who act as research experts based in chapters with an aim of ensuring that all JDRF families know how their investments are advancing the effort to cure type 1 diabetes. Tom also lives with T1D.
Since 2007 Tom has participated in multiple human clinical trials of artificial pancreas systems as well as human trials of new glucose sensing technology being developed as part of JDRF’s partnership with Becton Dickenson (BD). Most recently, in the fall of 2012, Tom was involved in early “real world” testing of an artificial pancreas system being developed with JDRF support at the University of Virginia. Leaving the hospital setting behind, for three days and two nights Tom was able to go out to dinner and lunch, take long walks, and explore the world while a smartphone based artificial pancreas system helped to automatically manage his blood glucose. Trials like this one are going on world-wide due to JDRF’s generous supporters.
Patricia Kilian, Ph.D, Director, Beta Cell Therapies, Regeneration
Patricia Kilian, Ph.D, serves as the Director of the Beta Cell Regeneration Program at JDRF, where she develops and implements strategic initiatives to accelerate the discovery of therapies to maintain and restore beta cell function in people with type 1 diabetes. In this capacity, she has established a number of industry and academic partnerships with leading institutions and is actively engaged in managing these research projects. In the area of diabetes, Dr. Kilian has extensive scientific and global management experience in both pharmaceutical and biotechnology companies. She has more than 50 scientific publications and patents.
Julia Greenstein, Ph.D, Assistant Vice President, Cure Therapies
Julia Greenstein, Ph.D, originally joined JDRF as a consultant in 2005 and currently serves as the Assistant Vice President of Cure Therapies, one of JDRF’s core research initiatives. Many of the projects in the Cure research portfolio also contribute toward our goal of preventing T1D. In her more than 20 years of experience in the corporate biotechnology arena, Dr. Greenstein has held various leadership positions that have helped accelerate discoveries to market.